Evermay Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.2K Hold
141
0.01% 279
2025
Q4
$95.4K Buy
141
+121
+605% +$82.4K 0.01% 263
2025
Q3
$12.8K Hold
20
﹤0.01% 426
2025
Q2
$10.7K Hold
20
﹤0.01% 441
2025
Q1
$8.4K Hold
20
﹤0.01% 458
2024
Q4
$8.27K Hold
20
﹤0.01% 458
2024
Q3
$10.1K Hold
20
﹤0.01% 461
2024
Q2
$9.74K Hold
20
﹤0.01% 458
2024
Q1
$10.8K Sell
20
-1
-5% -$546 ﹤0.01% 459
2023
Q4
$11.7K Buy
21
+1
+5% +$469 ﹤0.01% 438
2023
Q3
$8.75K Buy
+20
New +$9.97K ﹤0.01% 444

Other funds holding IDXX

Evermay Wealth Management's IDXX Position: Q1 2026 in Review

Evermay Wealth Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 141 shares worth $79.2K. The position accounts for 0.01% of the portfolio, ranked #279.

Evermay Wealth Management first reported a position in IDXX in Q3 2023 and has held it in 11 quarters since. The position peaked at $95.4K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Evermay Wealth Management held 141 shares of Idexx Laboratories worth $79.2K as of Q1 2026.
  • Evermay Wealth Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.01% of Evermay Wealth Management's portfolio in Q1 2026, its #279 holding.
  • Evermay Wealth Management first reported a position in Idexx Laboratories in Q3 2023 and has held it in 11 quarters since.
  • Evermay Wealth Management's Idexx Laboratories position peaked at $95.4K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.